Scholarlink

<p>Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based modeling and machine learning in digital twins. The physics-based model considers PSA secretion and flux from tissue to blood, depending on local vascularity. This model is enhanced by deep learning, which regulates tumor growth dynamics through the patient’s PSA blood tests and 3D spatial interactions of physiological variables of the digital twin. We showcase our framework by reconstructing tumor growth in real patients over 2.5 years from diagnosis, with tumor volume relative errors ranging from 0.8% to 12.28%. Additionally, our results reveal scenarios of tumor growth despite no significant rise in PSA levels. Therefore, our framework serves as a promising tool for prostate cancer monitoring, supporting the advancement of personalized monitoring protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Physics-informed machine learning digital twin for reconstructing prostate cancer tumor growth via PSA tests

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月29日

查看全文
  • Daniel Camacho-Gomez,
  • Carlos Borau,
  • Jose Manuel Garcia-Aznar,
  • Maria Jose Gomez-Benito,
  • Mark Girolami,
  • Maria Angeles Perez

摘要

Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based modeling and machine learning in digital twins. The physics-based model considers PSA secretion and flux from tissue to blood, depending on local vascularity. This model is enhanced by deep learning, which regulates tumor growth dynamics through the patient’s PSA blood tests and 3D spatial interactions of physiological variables of the digital twin. We showcase our framework by reconstructing tumor growth in real patients over 2.5 years from diagnosis, with tumor volume relative errors ranging from 0.8% to 12.28%. Additionally, our results reveal scenarios of tumor growth despite no significant rise in PSA levels. Therefore, our framework serves as a promising tool for prostate cancer monitoring, supporting the advancement of personalized monitoring protocols.